Compare Hims and Hers Health Inc (HIMS) vs Target Corporation (TGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Target Corporation — how do they compare? Hims and Hers Health Inc trades at $33.45 (market cap $7.57B), while Target Corporation trades at $138.6 (market cap $63.40B). The key difference: Target Corporation is far larger — about 8.4× Hims and Hers Health Inc's market cap, and Target Corporation pays a 3.32% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| HIMS | TGT | |
|---|---|---|
Market Cap | $7.57B | $63.40B |
Sector | Health | Consumer Cyclical |
52-Week High | $66.18 | $141.19 |
52-Week Low | $14.52 | $83.68 |
Enterprise Value | $7.95B | $78.70B |
Dividend Yield | — | 3.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health trades at $32.70, down 0.43% on the day, with a bearish technical signal despite bullish moving averages. The company reported $2.35 billion in 2025 revenue but swung to a projected net loss for 2026, with mixed quarterly earnings results. Recent news highlights executive changes and anticipation for Q2 2026 results on August 10, 2026, with analyst sentiment leaning toward a Buy consensus.
The outlook is cautious due to profitability concerns and high valuation multiples, but growth opportunities in weight-loss and telehealth services offer potential. Key risks include execution challenges and regulatory scrutiny. The stock presents a speculative growth play with a consensus price target of $33.57, slightly above the current price.
Target (TGT) trades at $139.11, down 0.37% on the day, with a bullish technical outlook supported by moving averages and recent earnings beats. The stock shows solid fundamentals with a P/E of 18.44, P/S of 0.6, and ROE of 22.02%, while revenue remains stable around $106 billion. Positive sentiment is driven by improved traffic trends and merchandising updates noted by Jefferies on July 15, 2026.
Target presents a balanced opportunity with strong profitability and analyst support, though risks include competitive retail pressures and margin volatility. The consensus price target of $137 suggests limited upside, but consistent dividend payments and operational cash flow near $7.4 billion provide stability. Execution on merchandising initiatives will be key for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →
